Guiding principles in the design of molecular bioconjugates for vaccine applications. - Wikidata - awgldk - TriplyDB

Guiding principles in the design of molecular bioconjugates for vaccine applications.

Guiding principles in the design of molecular bioconjugates for vaccine applications.

http://www.wikidata.org/entity/Q38395963

about

Engineering opportunities in cancer immunotherapy Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.Modulation of Innate Immune Responses via Covalently Linked TLR Agonists.In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence.Strategies for designing synthetic immune agonists.Nanomedicine approaches to improve cancer immunotherapy.Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity.Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach.Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity.Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.Overcoming formulation challenges for the next generation of vaccines.Vaccine delivery: where polymer chemistry meets immunology.

P2860

Q26776373-83C4C82F-70FB-42C1-8F5A-B87559B466FA Q33792946-2B208D0F-CFE8-42AE-8DF2-B18F03BE616F Q36333881-A7C9464A-DB3A-4180-80AE-70917A4BA585 Q37512939-7FCE0CF1-DB28-4C78-BFEF-5FD006F8819A Q38841677-7E026CC1-C76D-4339-AA3F-C80D3E012B8D Q39179977-5C5A2682-5EE8-4E33-BB0C-10B91F0BE209 Q41828763-D94123E9-0843-44BA-960E-A27D8F0798FD Q46429495-524EE06F-6A48-43C4-BB8D-47F07C9EDBFB Q48504870-59B45517-5514-448D-827C-C4EE7EE2B1F4 Q50863077-61FF3540-DAA0-4769-9994-2CB7EC6A9B64 Q51161865-3F7835F4-0F77-45C6-B869-E85B6A04880F Q51419339-E3D15BE7-14D3-4930-9E6D-B0A110CEAA07

P2860

Guiding principles in the design of molecular bioconjugates for vaccine applications.

http://www.wikidata.org/entity/Q38395963

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Guiding principles in the design of molecular bioconjugates for vaccine applications.

@en

type

label

Guiding principles in the design of molecular bioconjugates for vaccine applications.

@en

prefLabel

Guiding principles in the design of molecular bioconjugates for vaccine applications.

@en

P1433

Q38395963-4C467985-23B4-4968-A3C5-07D45709252A

P1476

Q38395963-587FAF71-599A-4C3C-89CD-1D0748C3D0C0

P2093

Q38395963-22320EF2-C0DE-4037-8652-88C383B55961

Q38395963-8D7A0DCD-9D4B-43CD-BCCB-D6A09AE0C6D0

P2860

Q38395963-00051BEE-F517-47C1-AB6B-3C14A1CE9C26

Q38395963-0195B4EA-E159-4195-A9B4-4BA6D711AB8B

Q38395963-0661E733-36B4-4258-BB4E-0482C36687C7

Q38395963-08C4B53A-2642-44D7-92FF-B092880912B6

Q38395963-10337E25-EA49-4BEA-BC99-C291A5B423BB

Q38395963-1085BD2F-7862-41C3-8A9D-936C0A2968AC

Q38395963-10CB00B6-7310-4D05-A7BC-D5B41A82BBD9

Q38395963-16283B0C-478C-4218-A834-8C435C7DF3F6

Q38395963-17ED9403-601D-4655-8C14-46567CEA14A5

Q38395963-185F4261-9A7A-483E-A24B-F8EA18EF31A7

P304

Q38395963-3D2E1A8D-647D-475D-ADA0-816B4055E894

P31

Q38395963-CACFBCB0-CEE4-4D7C-AE45-E1E867A61EEC

P356

Q38395963-E8EA9770-3363-4DC5-A725-9B8A4461E99C

P433

Q38395963-395767A8-2BDC-4B00-A539-1B4CA24F2E31

P478

Q38395963-8E88AB4C-7866-479D-BC1D-C2ADB5A6A43D

P577

Q38395963-15427617-5191-4AE5-8533-F71BC68AD60F

P698

Q38395963-C3FC47DA-E4F3-4D7D-9517-7988AF867889

P921

Q38395963-544BC298-32E7-420C-A815-B945EB8CA5DE

P932

Q38395963-21085C71-B45A-4094-882C-D05D37EC0EFB

P356

ACS.BIOCONJCHEM.5B00103

P1433

Bioconjugate Chemistry

P1476

Guiding principles in the design of molecular bioconjugates for vaccine applications.

@en

P2093

Darrell J Irvine

http://www.w3.org/2001/XMLSchema#string

Haipeng Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccines: from empirical development to rational design

Cancer immunotherapy comes of age

Preparation and evaluation of antigen/N-trimethylaminoethylmethacrylate chitosan conjugates for nasal immunization.

Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.

pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.

Structure-based programming of lymph-node targeting in molecular vaccines.

Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers

Ten great public health achievements--United States, 1900-1999.

Aptamer-targeted antigen delivery.

Danger signals: SOS to the immune system.

P304

791-801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACS.BIOCONJCHEM.5B00103

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25822926

http://www.w3.org/2001/XMLSchema#string

P921

molecular design

P932

4694040

http://www.w3.org/2001/XMLSchema#string